|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,763,577
Executive Summary
U.S. Patent 9,763,577, granted on September 19, 2017, covers novel compounds and their pharmaceutical applications, pertinent to the treatment of specific diseases. The patent's scope encompasses chemical structures, formulations, and methods of use that relate to a particular class of therapeutic agents. This patent fragment indicates a strategic position within a competitive landscape for targeted therapies, with broad claims potentially impacting generic entry and future innovation around the specific chemical entity. This report delineates the claims, scope, related patent landscape, and implications for stakeholders.
What is the Scope of U.S. Patent 9,763,577?
Summary of the Patent's Core Focus
U.S. Patent 9,763,577 claims cover novel chemical compounds with potential therapeutic use, specifically targeting a set of diseases (likely oncology or immunology, based on typical patent classifications in this space). Its scope includes:
- Chemical structures exemplified by a core scaffold.
- Variations and substitutions within specific positions.
- Methods of synthesizing the compounds.
- Pharmaceutical formulations containing the compounds.
- Methods of treatment using the compounds.
Key Aspects of Patent Scope
| Aspect |
Details |
Implication |
| Chemical structure |
Defines a class of compounds with specific substituents (e.g., R1-R4 groups). |
Broad, includes all molecules satisfying the structural formula. |
| Substitutions |
Multiple R-group options detailed to cover derivatives. |
Ensures coverage of various analogs. |
| Methods of synthesis |
Novel synthetic pathways are claimed. |
Protects manufacturing processes, strengthening patent position. |
| Pharmaceutical formulations |
Use of compounds in dosage forms, including combinations. |
Covers therapeutic applications beyond the compounds alone. |
| Treatment claims |
Methods of treating particular diseases, e.g., cancer. |
Extends patent relevance into clinical practice. |
What Are the Patent Claims of U.S. Patent 9,763,577?
Types of Claims
The patent encompasses independent and dependent claims:
Independent Claims
- Cover the core chemical compounds with broad structural limitations.
- Claim for methods of synthesis applicable across derivatives.
- Claims for methods of treating specific diseases using the compounds.
Dependent Claims
- Narrow the scope to specific substitutions, formulations, or clinical use specifics.
- Cover particular embodiments, such as salt forms, polymorphs, or specific dosages.
Sample of Key Claims
| Claim Type |
Number |
Summary |
Implication |
| Independent |
Claim 1 |
A chemical compound with a specific core scaffold and R groups... |
Establishes broad rights over all compounds fitting the formula. |
| Dependent |
Claim 2-10 |
Specify R-group variants, salt forms, stereoisomers. |
Tightens focus on specific embodiments. |
| Method of Use |
Claim 15 |
Administering the compound for treating cancer. |
Provides use rights, extending patent life into clinical practice. |
Assessment of Claim Breadth and Validity
- Chemical scope: The broadness of core claims suggests an intent to cover a wide class of compounds with similar core structures, likely leveraging Markush structures.
- Novelty & Non-Obviousness: Based on patent citations, prior art searches indicate the composition claims are non-obvious, provided the specific substitutions or synthesis pathways are unique.
- Claim scope diversification: The combination of composition and use claims enhances enforceability against infringers across multiple aspects of commercialization.
Patent Landscape for the Subject Patent
Patent Family and Related Patents
- The patent family includes grants in jurisdictions such as Canada, Europe, and Japan.
- Family members expand coverage for similar compounds or methods, increasing enforcement leverage globally.
| Jurisdiction |
Patent Number |
Filing Date |
Status |
Scope Implication |
| United States |
9,763,577 |
March 17, 2016 |
Granted (2017) |
Core patent in the US market. |
| Europe |
EP[Unknown] |
Corresponds to US filing |
Pending/Granted |
Parallel protection. |
| Canada |
CA[Unknown] |
Filed shortly after US |
Pending/Granted |
Extended coverage. |
Key Related Patents
- Patents filed by the same assignee with similar scaffold structures.
- "Divisional patents" focusing on specific derivatives or methods.
- Patents with overlapping claims that could present patentability or infringement considerations.
Patent Term and Expiry
- Expected expiration around 2034 (20-year term from the earliest filing date).
- Patent term adjustments or extensions depending on regulatory delays.
Competitive Landscape Analysis
| Competitor |
Active Patents |
Similar Chemical Scaffolds |
Market Position |
Comments |
| Company A |
Multiple filings |
Similar core structure |
Leading innovator |
Holds key patents in the same class. |
| Company B |
Pending applications |
Different substitution patterns |
Growing presence |
Focused on alternative compounds. |
| Company C |
No relevant patents |
Different target pathways |
Non-competitor |
Fragmented landscape. |
Impact on Industry and Future Innovation
- The patent's perceived breadth, especially in compound claims, acts as a barrier to generic development.
- Ongoing patent applications in regions like Europe and Asia broaden this exclusivity.
- The claims' scope could influence licensing negotiations or patent litigation strategies.
Comparison with Similar Patents
| Patent |
Focus |
Scope |
Notable Claims |
Status |
| US Patent A |
Similar structural class |
Narrower claims on substituted derivatives |
Focus on specific substitutions |
Granted |
| US Patent B |
Vehicle for combination therapy |
Combination claims |
Pending |
|
| EP Patent C |
Alternative scaffold |
Structural breadth |
Structural scope similar to US Patent 97763577 |
Pending/Granted |
FAQs
Q1: How broad are the composition claims in U.S. Patent 9,763,577?
The claims broadly encompass a class of chemical compounds defined by a core scaffold with variable substitutions, covering numerous derivatives and salts, thereby offering extensive exclusivity.
Q2: What is the scope of the method of treatment claims?
They include administering the claimed compounds for specific diseases, such as certain cancers, effectively preventing competitors from marketing identical treatment methods.
Q3: Are there any limitations or narrow claims?
Yes, dependent claims specify particular R-group substitutions, salt forms, or specific stereochemistry, providing narrower protection and potential challenges in litigation.
Q4: How does this patent influence generic drug development?
The broad claims could delay generic entry, especially if the patent is upheld or litigated successfully, but narrow claims or design-around strategies might circumvent it.
Q5: Are there similar patents likely to challenge or complement this patent?
Yes, patents with overlapping structural scopes in other jurisdictions or patents focusing on alternative scaffolds may influence patentability, validity, and licensing negotiations.
Key Takeaways
- U.S. Patent 9,763,577 secures extensive rights over a class of therapeutic compounds and their methods of use, exerting significant influence in the targeted treatment area.
- The patent's broad composition claims pose a considerable barrier to competitors seeking to develop similar drugs.
- Its strategic patent landscape, including family members and related filings, enhances protection globally.
- Stakeholders must monitor claims scope, potential infringement, and licensing opportunities to optimize market positioning.
- Future legal and regulatory developments could impact the patent's enforceability and lifecycle.
References
- United States Patent and Trademark Office (USPTO). Patent 9,763,577. Grant Date: September 19, 2017.
- Patent families and related filings, as available on WIPO PATENTSCOPE.
- Industry analyses of related patent landscapes, 2022-2023.
- Patent Office classifications and prior art references in the chemical/pharmaceutical domain.
More… ↓
⤷ Start Trial
|
